Transcript: GMO’s Matt Kadnar
The transcript from this week’s MIB: Matt Kadnar of GMO is below. You can stream/download the full conversation,...
MIB: Matt Kadnar of GMO
This week, we speak with Matthew Kadnar of Grantham, Mayo, & van Otterloo, where he is a member of the firm’s asset allocation...
RWM: We’re Coming to Chicago
Later this month, myself and my director of financial planning, Kris Venne will be in Chicago for the week. Readers of our stuff...
MIB: Not your Grandfather’s Emerging Markets
Think of investing in emerging markets (EM), and one tends to think of commodities, and therefore the U.S. dollar. That may have been...
Transcript: Lazard’s James Donald
The transcript from this week’s MIB with Lazard’s James Donald is below. You can stream/download the full...
MIB: Lazard’s James Donald
This week, we sit down Lazard Asset Management’s James Donald, who serves as head of its Emerging Markets Equity team. He serves as...
Batnick: Allocations During Volatility
Michael Batnick, research director at Ritholtz Wealth Management, sits down with Bloomberg’s Scarlet Fu, Eric Balchunas and Rachel...
Global Assets, 1900 – 2017
Via Credit Suisse Meb Faber’s Idea Farm reminds us that the Credit Suisse Global Investment Returns Yearbook 2018 should be...
Matching Goals, Risks and Investment Horizons
The key takeaway from this is to align portfolio risk levels with time horizon . . . Source: Ronald Blue & Co.
Investing in an Overpriced World
“What should an investor do when all asset classes appear overpriced? The 10-year U.S. Treasury bond currently yields about...